SOURCE: TraceLink Inc.

TraceLink Inc.

May 23, 2012 09:12 ET

TraceLink Discusses How the Cloud and Enterprise 2.0 Ensures Supply, Capacity and Quality at ISPE Pharmaceutical Supply Networks Conference

WOBURN, MA--(Marketwire - May 23, 2012) - TraceLink Inc., helping businesses securely supply every global market opportunity on-time and in-full with the TraceLink Business Cloud, announced today that Shabbir Dahod, TraceLink's President and CEO, will be speaking at ISPE's Designing, Implementing and Maintaining Pharmaceutical Supply Networks conference taking place June 6-7 in Baltimore, MD. The conference provides a detailed look at critical elements of the pharmaceutical supply chain, as the industry rapidly changes with the introduction of new technology and regulations.

At the conference, Mr. Dahod will present a session titled "Leveraging Cloud and Enterprise 2.0 to Securely Supply Every Global Market Opportunity On-Time and In-Full" on June 6th at 3:45 pm ET. This presentation will combine real-world examples with recent research on supply network collaboration to explore:

  • Global "pharmerging" market growth, outsourced manufacturing expansion and pharmaceutical traceability and serialization regulations that are driving change in supply and demand strategies;
  • A high-performance, agile supply network architecture based on cloud computing, multi-enterprise collaboration workspaces and innovative network-wide data integration approaches; and,
  • Benefits gained through better supply network information and collaboration in improved order fulfillment, decreased time-to-market, accurate inventory visibility and reduced compliance risk.

"As Life Science companies seek to maximize revenue growth from global markets and cost savings from global outsourcing, they require a new model for managing production, quality and inventory with CMO/CPOs, material suppliers and distribution partners," said Shabbir Dahod, President and CEO of TraceLink. "Visibility across all external supply relationships, access to accurate and timely data and cross-functional, cross-company collaboration is crucial in this environment. I am honored to drive discussion at this important event on the supply chain capabilities required to ensure supply, capacity, quality and compliance in today's global, virtual supply network."

Mr. Dahod will be joining a noted group of experts on supply network issues, pharmaceutical quality, patient safety and globalization from companies such as Pfizer, Eli Lilly, Johnson & Johnson, Shire and DSM Pharmaceuticals.

To learn more about TraceLink's solutions for creating an integrated and collaborative supply network, reducing risk through external quality management and oversight, improving supply planning with agile S&OP collaboration and protecting drug products from counterfeiting and theft such as the recent Genentech's Avastin and Eli Lilly's Prozac with safe and secure global distribution, visit

About TraceLink
TraceLink helps companies securely supply every global market opportunity on-time and in-full through the TraceLink Business Cloud. The TraceLink Business Cloud is a cloud-based application platform that connects business transactions, partner networks and professional relationships across companies and functions. The result is improved visibility, predictability and performance across global supply, manufacturing and distribution operations. The TraceLink Business Cloud combines an "integrate-once, interoperate-with-everyone" transaction translation platform, user-managed business collaboration workspaces and cross-linked business process modules on a globally elastic cloud infrastructure to help companies realize their strategic goals in improving global supply network performance.

TraceLink is funded by FirstMark Capital, a venture capital firm managing more than $2 billion in capital commitments. For more information on TraceLink and our solutions, visit

Contact Information

  • Contact:
    Brian Daleiden
    TraceLink Inc.
    Email Contact